|
1
|
Sathe A and Nawroth R: Targeting the
PI3K/AKT/mTOR Pathway in Bladder Cancer. Methods Mol Biol.
1655:335–350. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X and Zhang Y: Bladder cancer and
genetic mutations. Cell Biochem Biophys. 73:65–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mao XW, Xiao JQ, Li ZY, Zheng YC and Zhang
N: Effects of microRNA-135a on the epithelial-mesenchymal
transition, migration and invasion of bladder cancer cells by
targeting GSK3β through the Wnt/β-catenin signaling pathway. Exp
Mol Med. 50:e4292018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie H, Liao X, Chen Z, Fang Y, He A, Zhong
Y, Gao Q, Xiao H, Li J, Huang W and Liu Y: LncRNA MALAT1 inhibits
apoptosis and promotes invasion by antagonizing miR-125b in bladder
cancer cells. J Cancer. 8:3803–3811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mitra AP: Molecular substratification of
bladder cancer: Moving towards individualized patient management.
Ther Adv Urol. 8:215–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smolle MA and Pichler M: The role of long
non-coding RNAs in osteosarcoma. Noncoding RNA. 4(pii):
E72018.PubMed/NCBI
|
|
9
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17:612018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong W, Huang C, Deng H, Jian C, Zen C,
Ye K, Zhong Z, Zhao X and Zhu L: Oncogenic non-coding RNA NEAT1
promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT
pathway. Int J Biochem Cell Biol. 94:125–132. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cen C, Li J, Liu J, Yang M, Zhang T, Zuo
Y, Lin C and Li X: Long noncoding RNA LINC01510 promotes the growth
of colorectal cancer cells by modulating MET expression. Cancer
Cell Int. 18:452018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Cui Y, Liu LF, Ren WB, Li QQ, Zhou
X, Li YL, Li Y, Bai XY and Zu XB: High expression of long noncoding
RNA MALAT1 indicates a poor prognosis and promotes clinical
progression and metastasis in bladder cancer. Clin Genitourin
Cancer. 15:570–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo J, Chen J, Li H, Yang Y, Yun H, Yang S
and Mao X: LncRNA UCA1 promotes the invasion and EMT of bladder
cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett.
14:5556–5562. 2017.PubMed/NCBI
|
|
14
|
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X,
Wang M, Huang C, Wang L, Zeng F and Jiang G: LncRNA SPRY4-IT1
sponges miR-101-3p to promote proliferation and metastasis of
bladder cancer cells through up-regulating EZH2. Cancer Lett.
388:281–291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhai X and Xu W: Long noncoding RNA ATB
promotes proliferation, migration and invasion in bladder cancer by
suppressing microRNA-126. Oncol Res. 26:1063–1072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang M, Guo C, Wang L, Luo G, Huang C, Li
Y, Liu D, Zeng F, Jiang G and Xiao X: Long noncoding RNA GAS5
promotes bladder cancer cells apoptosis through inhibiting EZH2
transcription. Cell Death Dis. 9:2382018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Migeon BR: Choosing the Active X: The
human version of X inactivation. Trends Genet. 33:899–909. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shenoda BB, Tian Y, Alexander GM,
Aradillas-Lopez E, Schwartzman RJ and Ajit SK: miR-34a-mediated
regulation of XIST in female cells under inflammation. J Pain Res.
11:935–945. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, Chen B, Liu P and Yang J: XIST
promotes gastric cancer (GC) progression through TGF-β1 via
targeting miR-185. J Cell Biochem. 119:2787–2796. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu H, Zheng T, Yu J, Zhou L and Wang L:
LncRNA XIST accelerates cervical cancer progression via
upregulating Fus through competitively binding with miR-200a.
Biomed Pharmacother. 105:789–797. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu R, Zhu X, Chen F, Huang C, Ai K, Wu H,
Zhang L and Zhao X: LncRNA XIST/miR-200c regulates the stemness
properties and tumourigenicity of human bladder cancer stem
cell-like cells. Cancer Cell Int. 18:412018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu Y, Deng C, Zhang H, Zhang J, Peng B and
Hu C: Long non-coding RNA XIST promotes cell growth and metastasis
through regulating miR-139-5p mediated Wnt/β-catenin signaling
pathway in bladder cancer. Oncotarget. 8:94554–94568. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei W, Liu Y, Lu Y, Yang B and Tang L:
LncRNA XIST promotes pancreatic cancer proliferation through
miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kruger J and Rehmsmeier M: RNAhybrid:
microRNA target prediction easy, fast and flexible. Nucleic Acids
Res. 34:W451–W454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao Z, Qu Z, Chen Z, Fang Z, Zhou K,
Huang Z, Guo X and Zhang Y: LncRNA HOTAIR is a prognostic biomarker
for the proliferation and chemoresistance of colorectal cancer via
MiR-203a-3p-mediated Wnt/ß-catenin signaling pathway. Cell Physiol
Biochem. 46:1275–1285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu K, Yao H, Wen Y, Zhao H, Zhou N, Lei S
and Xiong L: Functional role of a long non-coding RNA
LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to
pohotodynamic therapy. Biochim Biophys Acta Mol Basis Dis.
1864:2871–2880. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang H, Zhang H, Hu X and Li W: Knockdown
of long non-coding RNA XIST inhibits cell viability and invasion by
regulating miR-137/PXN axis in non-small cell lung cancer. Int J
Biol Macromol. 111:623–631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Z, Xu J, Lu H, Lin B, Cai S, Guo J,
Zang F and Chen R: LARP1 is regulated by the XIST/miR-374a axis and
functions as an oncogene in non-small cell lung carcinoma. Oncol
Rep. 38:3659–3667. 2017.PubMed/NCBI
|
|
31
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun Z, Zhang B and Cui T: Long non-coding
RNA XIST exerts oncogenic functions in pancreatic cancer via
miR-34a-5p. Oncol Rep. 39:1591–1600. 2018.PubMed/NCBI
|
|
33
|
Xiong Y, Wang L, Li Y, Chen M, He W and Qi
L: The long non-coding RNA XIST interacted with MiR-124 to modulate
bladder cancer growth, invasion and migration by targeting androgen
receptor (AR). Cell Physiol Biochem. 43:405–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang L, Xu J, Yang G, Li H and Guo X:
miR-202 inhibits cell proliferation, migration, and invasion by
targeting EGFR in human bladder cancer. Oncol Res. 26:949–957.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Uchida Y, Chiyomaru T, Enokida H, Kawakami
K, Tatarano S, Kawahara K, Nishiyama K, Seki N and Nakagawa M:
MiR-133a induces apoptosis through direct regulation of GSTP1 in
bladder cancer cell lines. Urol Oncol. 31:115–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Y, Wu D, Tao J, Qu P, Zhou Z and Hou
J: MicroRNA-133 inhibits cell proliferation, migration and invasion
by targeting epidermal growth factor receptor and its downstream
effector proteins in bladder cancer. Scand J Urol. 47:423–432.
2013. View Article : Google Scholar : PubMed/NCBI
|
